Thousands of patients with heart failure are set to benefit from the expansion Thousands of patients with heart failure are set to benefit from the expansion The NHS has announced the expansion of its ...

The new technology was safely trialled on 20 healthy volunteers for the first time ever The new technology was safely trialled on 20 healthy volunteers for the first time ever Researchers at the UK ...

We can now create synthetic human embryos – embryoids – from stem cells, without the need for sperm or eggs. Published in Nature in September, a research group from the Weizmann Institute in Israel ...

The proposed changes could limit patients’s access to treatments and clinical trials The proposed changes could limit patients’s access to treatments and clinical trials The National Economic Research ...

MHRA’s new 'International Recognition Procedure' – how does it shape up? MHRA’s new ‘International Recognition Procedure’ – how does it shape up? The field of life sciences and medicine development ...

The report highlights steps needed to ensure future pandemics are handled effectively The report highlights steps needed to ensure future pandemics are handled effectively The UK Research and ...

The ODD will offer clinical development and commercialisation benefits that will strengthen the drug programme The ODD will offer clinical development and commercialisation benefits that will ...

The decision follows a recent recommendation from the European Medicines Agency’s human medicines committee The decision follows a recent recommendation from the European Medicines Agency’s human ...

Therapy targets the coronavirus PLPRO enzyme essential for the evasion of host immune response Therapy targets the coronavirus PLPRO enzyme essential for the evasion of host immune response Infex ...

Avacta – a company developing oncology diagnostics and drugs – has announced that the fifth dose escalation cohort regarding its ALS-6000 candidate. The phase 1 research was evaluating the ...

The therapy treats adults with chronic hepatitis delta virus and compensated liver disease The therapy treats adults with chronic hepatitis delta virus and compensated liver disease Gilead Sciences ...